Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Safety, Pharmacokinetics and Haemodynamic Effect of a Slow Release Oral Formulation of Milrinone

NCT01849094 is registered in ClinicalTrials.gov with The Alfred as lead sponsor.

NCT NCT01849094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01849094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Safety, Pharmacokinetics and Haemodynamic Effect of a Slow Release Oral Formulation of Milrinone
Lead sponsor
The Alfred
Phase
Phase 1/2
Overall status
Completed
Start date
May 31, 2013
Completion date
December 31, 2014
Enrollment
9 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, heart failure